A citation-based method for searching scientific literature

Stanislav Drápela, Jan Bouchal, Mohit Kumar Jolly, Zoran Culig, Karel Souček. Front Mol Biosci 2020
Times Cited: 62







List of co-cited articles
432 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.
Peijing Zhang, Yongkun Wei, Li Wang, Bisrat G Debeb, Yuan Yuan, Jinsong Zhang, Jingsong Yuan, Min Wang, Dahu Chen, Yutong Sun,[...]. Nat Cell Biol 2014
289
12

EMT: 2016.
M Angela Nieto, Ruby Yun-Ju Huang, Rebecca A Jackson, Jean Paul Thiery. Cell 2016
12

ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM.
Xiang Zhang, Zhen Zhang, Qing Zhang, Quansheng Zhang, Peiqing Sun, Rong Xiang, Guosheng Ren, Shuang Yang. Cell Death Dis 2018
68
12

Identification of the tumour transition states occurring during EMT.
Ievgenia Pastushenko, Audrey Brisebarre, Alejandro Sifrim, Marco Fioramonti, Tatiana Revenco, Soufiane Boumahdi, Alexandra Van Keymeulen, Daniel Brown, Virginie Moers, Sophie Lemaire,[...]. Nature 2018
683
11

The roles of ZEB1 in tumorigenic progression and epigenetic modifications.
Yu Zhang, Lei Xu, Anqi Li, Xiuzhen Han. Biomed Pharmacother 2019
73
11

Epithelial-mesenchymal transitions in development and disease.
Jean Paul Thiery, Hervé Acloque, Ruby Y J Huang, M Angela Nieto. Cell 2009
11

Molecular mechanisms of epithelial-mesenchymal transition.
Samy Lamouille, Jian Xu, Rik Derynck. Nat Rev Mol Cell Biol 2014
11

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
9

The Physics of Cellular Decision Making During Epithelial-Mesenchymal Transition.
Shubham Tripathi, Herbert Levine, Mohit Kumar Jolly. Annu Rev Biophys 2020
39
15

Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
Cornelia Kröger, Alexander Afeyan, Jasmin Mraz, Elinor Ng Eaton, Ferenc Reinhardt, Yevgenia L Khodor, Prathapan Thiru, Brian Bierie, Xin Ye, Christopher B Burge,[...]. Proc Natl Acad Sci U S A 2019
209
9

Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution.
Loukia G Karacosta, Benedict Anchang, Nikolaos Ignatiadis, Samuel C Kimmey, Jalen A Benson, Joseph B Shrager, Robert Tibshirani, Sean C Bendall, Sylvia K Plevritis. Nat Commun 2019
95
9

Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum.
Priyanka Chakraborty, Jason T George, Shubham Tripathi, Herbert Levine, Mohit Kumar Jolly. Front Bioeng Biotechnol 2020
38
15


The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance.
Florian A Siebzehnrubl, Daniel J Silver, Bugra Tugertimur, Loic P Deleyrolle, Dorit Siebzehnrubl, Matthew R Sarkisian, Kelly G Devers, Antony T Yachnis, Marius D Kupper, Daniel Neal,[...]. EMBO Mol Med 2013
262
9

Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.
Hua-Tao Wu, Hui-Ting Zhong, Guan-Wu Li, Jia-Xin Shen, Qian-Qian Ye, Man-Li Zhang, Jing Liu. J Transl Med 2020
49
12

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
Limo Chen, Don L Gibbons, Sangeeta Goswami, Maria Angelica Cortez, Young-Ho Ahn, Lauren A Byers, Xuejun Zhang, Xiaohui Yi, David Dwyer, Wei Lin,[...]. Nat Commun 2014
608
8

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.
Tuan Zea Tan, Qing Hao Miow, Yoshio Miki, Tetsuo Noda, Seiichi Mori, Ruby Yun-Ju Huang, Jean Paul Thiery. EMBO Mol Med 2014
396
8

An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition.
Philip A Gregory, Cameron P Bracken, Eric Smith, Andrew G Bert, Josephine A Wright, Suraya Roslan, Melanie Morris, Leila Wyatt, Gelareh Farshid, Yat-Yuen Lim,[...]. Mol Biol Cell 2011
416
8

Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability.
Toni Celià-Terrassa, Caleb Bastian, Daniel D Liu, Brian Ell, Nicole M Aiello, Yong Wei, Jose Zamalloa, Andres M Blanco, Xiang Hang, Dmitriy Kunisky,[...]. Nat Commun 2018
88
8

Stability of the hybrid epithelial/mesenchymal phenotype.
Mohit Kumar Jolly, Satyendra C Tripathi, Dongya Jia, Steven M Mooney, Muge Celiktas, Samir M Hanash, Sendurai A Mani, Kenneth J Pienta, Eshel Ben-Jacob, Herbert Levine. Oncotarget 2016
243
8


A possible role for epigenetic feedback regulation in the dynamics of the epithelial-mesenchymal transition (EMT).
Wen Jia, Abhijeet Deshmukh, Sendurai A Mani, Mohit Kumar Jolly, Herbert Levine. Phys Biol 2019
47
10

Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Mahshad Kalantari, Reza Mohammadinejad, Tahereh Javaheri, Gautam Sethi. Int J Mol Sci 2020
100
8

Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins.
Antonio A Postigo, Jennifer L Depp, Jennifer J Taylor, Kristen L Kroll. EMBO J 2003
270
8

Context specificity of the EMT transcriptional response.
David P Cook, Barbara C Vanderhyden. Nat Commun 2020
73
8

Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Mohit Kumar Jolly, Jason A Somarelli, Maya Sheth, Adrian Biddle, Satyendra C Tripathi, Andrew J Armstrong, Samir M Hanash, Sharmila A Bapat, Annapoorni Rangarajan, Herbert Levine. Pharmacol Ther 2019
157
8

The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.
Steven M Mooney, Vida Talebian, Mohit Kumar Jolly, Dongya Jia, Monica Gromala, Herbert Levine, Brendan J McConkey. J Cell Biochem 2017
61
8

Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer.
Nora Feldker, Fulvia Ferrazzi, Harald Schuhwerk, Sebastian A Widholz, Kerstin Guenther, Isabell Frisch, Kathrin Jakob, Julia Kleemann, Dania Riegel, Ulrike Bönisch,[...]. EMBO J 2020
48
10

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
Ulrich Wellner, Jörg Schubert, Ulrike C Burk, Otto Schmalhofer, Feng Zhu, Annika Sonntag, Bettina Waldvogel, Corinne Vannier, Douglas Darling, Axel zur Hausen,[...]. Nat Cell Biol 2009
8

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges.
Chin-Yap Loh, Jian Yi Chai, Ting Fang Tang, Won Fen Wong, Gautam Sethi, Muthu Kumaraswamy Shanmugam, Pei Pei Chong, Chung Yeng Looi. Cells 2019
381
8

The epithelial-mesenchymal transition generates cells with properties of stem cells.
Sendurai A Mani, Wenjun Guo, Mai-Jing Liao, Elinor Ng Eaton, Ayyakkannu Ayyanan, Alicia Y Zhou, Mary Brooks, Ferenc Reinhard, Cheng Cheng Zhang, Michail Shipitsin,[...]. Cell 2008
6

Modeling continuum of epithelial mesenchymal transition plasticity.
Mousumi Mandal, Biswajoy Ghosh, Anji Anura, Pabitra Mitra, Tanmaya Pathak, Jyotirmoy Chatterjee. Integr Biol (Camb) 2016
31
12

Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2.
Jason A Somarelli, Samantha Shetler, Mohit K Jolly, Xueyang Wang, Suzanne Bartholf Dewitt, Alexander J Hish, Shivee Gilja, William C Eward, Kathryn E Ware, Herbert Levine,[...]. Mol Cell Biol 2016
58
6

The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cells.
Vin Yee Chung, Tuan Zea Tan, Jieru Ye, Rui-Lan Huang, Hung-Cheng Lai, Dennis Kappei, Heike Wollmann, Ernesto Guccione, Ruby Yun-Ju Huang. Commun Biol 2019
33
12


Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2.
Benjamin Cieply, Philip Riley, Phillip M Pifer, Joseph Widmeyer, Joseph B Addison, Alexey V Ivanov, James Denvir, Steven M Frisch. Cancer Res 2012
152
6

Identifying inhibitors of epithelial-mesenchymal plasticity using a network topology-based approach.
Kishore Hari, Burhanuddin Sabuwala, Balaram Vishnu Subramani, Caterina A M La Porta, Stefano Zapperi, Francesc Font-Clos, Mohit Kumar Jolly. NPJ Syst Biol Appl 2020
42
9

A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.
Nataly Stylianou, Melanie L Lehman, Chenwei Wang, Atefeh Taherian Fard, Anja Rockstroh, Ladan Fazli, Lidija Jovanovic, Micheal Ward, Martin C Sadowski, Abhishek S Kashyap,[...]. Oncogene 2019
49
8

Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.
Federico Bocci, Larisa Gearhart-Serna, Marcelo Boareto, Mariana Ribeiro, Eshel Ben-Jacob, Gayathri R Devi, Herbert Levine, José Nelson Onuchic, Mohit Kumar Jolly. Proc Natl Acad Sci U S A 2019
142
6

A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells.
Shubham Tripathi, Priyanka Chakraborty, Herbert Levine, Mohit Kumar Jolly. PLoS Comput Biol 2020
55
7

Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.
Brian Bierie, Sarah E Pierce, Cornelia Kroeger, Daniel G Stover, Diwakar R Pattabiraman, Prathapan Thiru, Joana Liu Donaher, Ferenc Reinhardt, Christine L Chaffer, Zuzana Keckesova,[...]. Proc Natl Acad Sci U S A 2017
167
6

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition.
Matthew J Hangauer, Vasanthi S Viswanathan, Matthew J Ryan, Dhruv Bole, John K Eaton, Alexandre Matov, Jacqueline Galeas, Harshil D Dhruv, Michael E Berens, Stuart L Schreiber,[...]. Nature 2017
573
6

Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.
Brent R Stockwell, José Pedro Friedmann Angeli, Hülya Bayir, Ashley I Bush, Marcus Conrad, Scott J Dixon, Simone Fulda, Sergio Gascón, Stavroula K Hatzios, Valerian E Kagan,[...]. Cell 2017
6

DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer.
Eva Galle, Bernard Thienpont, Sarah Cappuyns, Tom Venken, Pieter Busschaert, Matthias Van Haele, Eric Van Cutsem, Tania Roskams, Jos van Pelt, Chris Verslype,[...]. Clin Epigenetics 2020
35
11

Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles.
Marlies Cortés, Lidia Sanchez-Moral, Oriol de Barrios, María J Fernández-Aceñero, M C Martínez-Campanario, Anna Esteve-Codina, Douglas S Darling, Balázs Győrffy, Toby Lawrence, Douglas C Dean,[...]. EMBO J 2017
75
6

ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types.
Waltraut Lehmann, Dirk Mossmann, Julia Kleemann, Kerstin Mock, Chris Meisinger, Tilman Brummer, Ricarda Herr, Simone Brabletz, Marc P Stemmler, Thomas Brabletz. Nat Commun 2016
193
6

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
Jill E Larsen, Vaishnavi Nathan, Jihan K Osborne, Rebecca K Farrow, Dhruba Deb, James P Sullivan, Patrick D Dospoy, Alexander Augustyn, Suzie K Hight, Mitsuo Sato,[...]. J Clin Invest 2016
198
6

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
6

IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation.
Yijing Li, Lei Wang, Loretta Pappan, Amy Galliher-Beckley, Jishu Shi. Mol Cancer 2012
198
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.